Susquehanna International Group, LLP Vera Therapeutics, Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 19,684 shares of VERA stock, worth $663,350. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,684
Previous 11,109
77.19%
Holding current value
$663,350
Previous $401,000
116.71%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VERA
# of Institutions
185Shares Held
55.2MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$145 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$133 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$112 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$99.8 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$94.2 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $911M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...